MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 383-389

  Lei, Wanke ^a   Liu, Yun E ^b   Zheng, Yuzhu ^c   Qu, Lin ^d  

^a People s Hospital of Mianzhu   (China)

^b The Second Artillery General Hospital PLA   (China)

^c Third Hospital of Chengdu   (China)

^d Chengdu Military Region ^*  (China)

Author keywords

Cell Growth Processes; MicroRNAs; Mouth Neoplasms

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MICRORNA 429; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MIRN429 MICRORNA, HUMAN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MOUTH SQUAMOUS CELL CARCINOMA; MTT ASSAY; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ALGORITHM; BIOLOGY; CELL SEPARATION; CHEMISTRY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

ALGORITHMS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SEPARATION; COMPUTATIONAL BIOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; MOUTH NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84922361115     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893412     Document Type: Article

References (56)

1. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. Cancer J Clin, 2014; 64(1): 9–29
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. Cancer J Clin, 2013; 63(1): 11–30
3. Messadi DV, Wilder-Smith P, Wolinsky L: Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc, 2009; 37(11): 789–98
4. Han S, Chen Y, Ge X et al: Epidemiology and cost analysis for patients with oral cancer in a university hospital in China. BMC Public Health, 2010; 10: 196
5. Kademani D: Oral cancer. Mayo Clin Proc, 2007; 82(7): 878–87
6. Laronde DM, Hislop TG, Elwood JM, Rosin MP: Oral cancer: just the facts. J Can Dent Assoc, 2008; 74(3): 269–72
7. Schwartz SM, Daling JR, Doody DR et al: Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst, 1998; 90(21): 1626–36
8. Lippman SM, Sudbo J, Hong WK: Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol, 2005; 23(2): 346–56
9. Jemal A, Bray F, Center MM et al: Global cancer statistics. Cancer J Clin, 2011; 61(2): 69–90
10. Ambros V: microRNAs: tiny regulators with great potential. Cell, 2001; 107(7): 823–26
11. Kim VN, Han J, Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol, 2009; 10(2): 126–39
12. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell, 2009; 136(2): 215–33
13. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev, 2006; 20(5): 515–24
14. Garzon R, Calin GA, Croce CM: MicroRNAs in Cancer. Annu Rev Med, 2009; 60: 167–79
15. Ambros V: The functions of animal microRNAs. Nature, 2004; 431(7006): 350–55
16. Hou J, Lin L, Zhou W et al: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 2011; 19(2): 232–43
17. Liu C, Li B, Cheng Y et al: MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci, 2011; 7(3): 347–63
18. Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell, 2012; 148(6): 1172–87
19. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 2009; 10(10): 704–14
20. Jung HM, Patel RS, Phillips BL et al: Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions. Mol Biol Cell, 2013; 24(11): 1638–48, S1631–37
21. Henson BJ, Bhattacharjee S, O’Dee DM et al: Decreased expression of miR- 125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer, 2009; 48(7): 569–82
22. Wiklund ED, Gao S, Hulf T et al: MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PloS One, 2011; 6(11): e27840
23. Mongroo PS, Rustgi AK: The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther, 2010; 10(3): 219–22
24. Wang Y, Li M, Zang W et al: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol, 2013; 36(5): 385–94
25. Wu N, Liu C, Bai C et al: Over-Expression of Deubiquitinating Enzyme USP14 in Lung Adenocarcinoma Promotes Proliferation through the Accumulation of beta-Catenin. Int J Mol Sci, 2013; 14(6): 10749–60
26. Wu N, Zhang C, Bai C et al: MiR-4782-3p inhibited non-small cell lung cancer growth via USP14. Cell Physiol Biochem, 2014; 33(2): 457–67
27. van Meerloo J, Kaspers GJ, Cloos J: Cell sensitivity assays: the MTT assay. Methods Mol Biol, 2011; 731: 237–45
28. Han ZB, Yang Z, Chi Y et al: MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem, 2013; 31(6): 823–32
29. John B, Enright AJ, Aravin A et al: Human MicroRNA targets. PLoS Biol, 2004; 2(11): e363
30. Krek A, Grun D, Poy MN et al: Combinatorial microRNA target predictions. Nat Genet, 2005; 37(5): 495–500
31. Ma Q, Jiang Q, Pu Q et al: MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci, 2013; 9(7): 680–92
32. Zhou BR, Guo XF, Zhang JA et al: Elevated miR-34c-5p mediates dermal fibroblast senescence by ultraviolet irradiation. Int J Biol Sci, 2013; 9(7): 743–52
33. Coronnello C, Benos PV: ComiR: Combinatorial microRNA target prediction tool. Nucleic Acids Res, 2013; 41(Web Server issue): W159–64
34. Lewis BP, Shih IH, Jones-Rhoades MW et al: Prediction of mammalian microRNA targets. Cell, 2003; 115(7): 787–98
35. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG: miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res, 2007; 35 (Database issue): D149–55
36. Alexiou P, Vergoulis T, Gleditzsch M et al: miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res, 2010; 38 (Database issue): D137–41
37. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res, 2008; 36 (Database issue): D154–58
38. Bendoraite A, Knouf EC, Garg KS et al: Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol, 2010; 116(1): 117–25
39. Gregory PA, Bert AG, Paterson EL et al: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 2008; 10(5): 593–601
40. Liu X, Liu Y, Wu S et al: Tumor-suppressing effects of miR-429 on human osteosarcoma. Cell Biochem Biophys, 2014; 70(1): 215–24
41. Li D, Liu X, Lin L et al: MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem, 2011; 286(42): 36677–85
42. Reilly SM, Chiang SH, Decker SJ et al: An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nat Med, 2013; 19(3): 313–21
43. Hugo H, Ackland ML, Blick T et al: Epithelial – mesenchymal and mesenchymal – epithelial transitions in carcinoma progression. J Cell Physiol, 2007; 213(2): 374–83
44. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2002; 2(6): 442–54
45. Comijn J, Berx G, Vermassen P et al: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 2001; 7(6): 1267–78
46. Shirakihara T, Saitoh M, Miyazono K: Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell, 2007; 18(9): 3533–44
47. Spaderna S, Schmalhofer O, Wahlbuhl M et al: The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res, 2008; 68(2): 537–44
48. Vandewalle C, Comijn J, De Craene B et al: SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res, 2005; 33(20): 6566–78
49. Zuo JH, Zhu W, Li MY et al: Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem, 2011; 112 (9): 2508–17
50. Ho CM, Hu FW, Lee SS et al: ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas. J Oral Pathol Med, 2014 [Epub ahead of print]
51. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer, 2006; 6(11): 857–66
52. Mattick JS, Makunin IV: Small regulatory RNAs in mammals. Hum Mol Genet, 2005; 14 Spec No 1: R121–32
53. Tavazoie SF, Alarcon C, Oskarsson T et al: Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008; 451(7175): 147–52
54. Tie J, Fan D: Big roles of microRNAs in tumorigenesis and tumor development. Histol Histopathol, 2011; 26(10): 1353–61
55. Uhlmann S, Zhang JD, Schwager A et al: miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene, 2010; 29(30): 4297–306
56. Huang XY, Yao JG, Huang HD et al: MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. Gastroenterol Res Pract, 2013; 2013: 804128